Wide Ranks

CRGX

CARGO Therapeutics, Inc.

17.67

Top Statistics
Market Cap 813 M Forward PE -4.40 Revenue Growth 0.00 %
Current Ratio 18.95 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -2.57 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 404 M Total Cash Per Share 8.80 Total Debt 28 M
Total Debt To Equity 7.13 Current Ratio 18.95 Book Value Per Share 8.72
All Measures
Short Ratio 3180.00 % Message Board Id finmb_1800783773 Shares Short Prior Month 5 M
Return On Equity -0.6981 City San Mateo Uuid 86bef930-9b65-3deb-8753-55609cb7900d
Previous Close 17.23 First Trade Date Epoch Utc 1 B Book Value 8.72
Total Debt 28 M Volume 108724 Price To Book 2.03
Fifty Two Week Low 13.56 Total Cash Per Share 8.80 Shares Short Previous Month Date 1 B
Target Median Price 32.00 Max Age 86400 Recommendation Mean 1.38
Sand P52 Week Change 0.3133 Target Mean Price 31.71 Net Income To Common -154144000
Short Percent Of Float 0.1427 Implied Shares Outstanding 46 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 251400 Average Volume10days 251400
Total Cash 404 M Next Fiscal Year End 1 B Held Percent Insiders 0.0480
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 17.23 Target Low Price 28.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 19.61 Open 17.33 Free Cashflow -112934000
State CA Dividend Yield 0.00 % Return On Assets -0.4035
Time Zone Short Name EST Trailing Eps -17.59 Day Low 17.02
Address1 1900 Alameda De Las Pulgas Shares Outstanding 46 M Price Hint 2
Target High Price 34.00 Website https://cargo-tx.com 52 Week Change 0.1819
Average Volume 285523 Forward Eps -4.66 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 1883.90 % Is_sp_500 False
Regular Market Day High 17.81 Profit Margins 0.00 % Debt To Equity 7.13
Fifty Two Week High 33.92 Day High 17.81 Shares Short 5 M
Regular Market Open 17.33 Industry Key biotechnology Earnings Growth 0.00 %
Revenue Growth 0.00 % Shares Percent Shares Out 0.1231 Operating Cashflow -133837000
Currency USD Time Zone Full Name America/New_York Market Cap 813 M
Is_nasdaq_100 False Zip 94403 Quote Type EQUITY
Industry Biotechnology Long Name CARGO Therapeutics, Inc. Regular Market Day Low 17.02
Held Percent Institutions 1.10 Current Price 17.67 Address2 Suite 350
Enterprise To Ebitda -2.57 Financial Currency USD Current Ratio 18.95
Industry Disp Biotechnology Number Of Analyst Opinions 7 Country United States
Float Shares 30 M Two Hundred Day Average 19.79 Enterprise Value 437 M
Forward PE -4.40 Regular Market Volume 108724 Ebitda -169784992
Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies.

It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets.

The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022.

CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.